Charles Schwab
APYX icon

Charles Schwab’s Apyx Medical APYX Stock Holding History

Charles Schwab’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,288
Closed -$21.8K – 3506
2024
Q2 		$21.8K Buy
16,288
+3,800
+30% +$5.61K ﹤0.01% 3580
2024
Q1 		$17K Hold
12,488
– – ﹤0.01% 3439
2023
Q4 		$32.7K Hold
12,488
– – ﹤0.01% 3445
2023
Q3 		$40K Hold
12,488
– – ﹤0.01% 3425
2023
Q2 		$62.8K Hold
12,488
– – ﹤0.01% 3388
2023
Q1 		$36K Hold
12,488
– – ﹤0.01% 3410
2022
Q4 		$29.2K Hold
12,488
– – ﹤0.01% 3461
2022
Q3 		$57K Hold
12,488
– – ﹤0.01% 3298
2022
Q2 		$74K Sell
12,488
-70,684
-85% -$363K ﹤0.01% 3323
2022
Q1 		$544K Buy
83,172
+2,397
+3% +$23.6K ﹤0.01% 3073
2021
Q4 		$1.04M Buy
80,775
+2,360
+3% +$33K ﹤0.01% 2899
2021
Q3 		$1.09M Sell
78,415
-194
-0.2% -$2.04K ﹤0.01% 2844
2021
Q2 		$811K Sell
78,609
-5,523
-7% -$54.7K ﹤0.01% 3000
2021
Q1 		$813K Buy
84,132
+6,600
+9% +$66K ﹤0.01% 2920
2020
Q4 		$559K Hold
77,532
– – ﹤0.01% 2949
2020
Q3 		$366K Sell
77,532
-3,962
-5% -$19.6K ﹤0.01% 2970
2020
Q2 		$453K Buy
81,494
+3,254
+4% +$13.5K ﹤0.01% 2875
2020
Q1 		$281K Sell
78,240
-2,945
-4% -$19.8K ﹤0.01% 2915
2019
Q4 		$687K Buy
81,185
+3,281
+4% +$23.7K ﹤0.01% 2713
2019
Q3 		$528K Hold
77,904
– – ﹤0.01% 2778
2019
Q2 		$524K Buy
+77,904
New +$423K ﹤0.01% 2789

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Charles Schwab's APYX Position: Q3 2024 in Review

Charles Schwab sold out of Apyx Medical (APYX) in Q3 2024, closing a stake of 16,288 shares — an estimated $21.8K sold.

Charles Schwab first reported a position in APYX in Q2 2019 and held it in 21 quarters. The position peaked at $1.09M in Q3 2021. 45 funds tracked by Wall St. Rank hold APYX as of Q3 2024.

  • Charles Schwab reported no remaining Apyx Medical position as of Q3 2024 after selling out during the quarter.
  • Charles Schwab sold 16,288 Apyx Medical shares in Q3 2024, an estimated $21.8K.
  • Charles Schwab first reported a position in Apyx Medical in Q2 2019 and held it in 21 quarters.
  • Charles Schwab's Apyx Medical position peaked at $1.09M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2024.

Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.